Integral Health Asset Management, LLC Cytokinetics Inc Transaction History

Integral Health Asset Management, LLC

$850 Million
Q3 2024

A detailed history of Integral Health Asset Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 750,000 shares of CYTK stock, worth $36.7 Million. This represents 4.66% of its overall portfolio holdings.

Number of Shares

750,000

Previous 1,000,000 25.0%

Holding current value

$36.7 Million

Previous $54.2 Million 26.91%

% of portfolio

4.66%

Previous 5.21%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $12.8 Million - $15 Million	-250,000 Reduced 25.0%	750,000 $39.6 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $26.3 Million - $41.3 Million	550,000 Added 122.22%	1,000,000 $54.2 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $15.9 Million - $27 Million	250,000 Added 125.0%	450,000 $31.5 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $16.1 Million - $50.1 Million	-600,000 Reduced 75.0%	200,000 $16.7 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $4.42 Million - $5.49 Million	150,000 Added 23.08%	800,000 $23.6 Million
Q2 2023 Aug 11, 2023	BUY	$32.62 - $40.75 $1.63 Million - $2.04 Million	50,000 Added 8.33%	650,000 $21.2 Million
Q1 2023 May 09, 2023	BUY	$33.36 - $45.71 $6.67 Million - $9.14 Million	200,000 Added 50.0%	600,000 $21.1 Million
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $1.79 Million - $2.56 Million	50,000 Added 14.29%	400,000 $18.3 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $6.74 Million - $9.54 Million	-175,000 Reduced 33.33%	350,000 $17 Million
Q2 2022 Aug 03, 2022	BUY	$33.93 - $48.92 $1.87 Million - $2.69 Million	55,000 Added 11.7%	525,000 $20.6 Million
Q1 2022 May 12, 2022	BUY	$29.74 - $46.0 $4.31 Million - $6.67 Million	145,000 Added 44.62%	470,000 $17.3 Million
Q3 2021 Nov 12, 2021	SELL	$18.54 - $35.74 $6.95 Million - $13.4 Million	-375,000 Reduced 53.57%	325,000 $11.6 Million
Q2 2021 Aug 30, 2021	SELL	$19.79 - $26.99 $13.9 Million - $18.9 Million	-700,000 Reduced 50.0%	700,000 $13.9 Million
Q2 2021 Aug 13, 2021	BUY	$19.79 - $26.99 $13.9 Million - $18.9 Million	700,000 Added 100.0%	1,400,000 $27.7 Million
Q1 2021 May 10, 2021	BUY	$18.57 - $25.68 $3.25 Million - $4.49 Million	175,000 Added 33.33%	700,000 $16.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $4.96 Million - $9.3 Million	325,000 Added 162.5%	525,000 $10.9 Million
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $2.88 Million - $4.05 Million	-140,000 Reduced 41.18%	200,000 $4.33 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $223,000 - $492,800	20,000 Added 6.25%	340,000 $8.01 Million
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $2.8 Million - $5.22 Million	320,000 New	320,000 $3.77 Million

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Account

Integral Health Asset Management, LLC Cytokinetics Inc Transaction History